Meridian Investment Counsel Inc. Novo Nordisk A S Transaction History

Meridian Investment Counsel Inc.

$329 Million
Q4 2024

A detailed history of Meridian Investment Counsel Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Meridian Investment Counsel Inc. holds 45,697 shares of NVO stock, worth $3.6 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares

45,697

Previous 23,383 95.43%

Holding current value

$3.6 Million

Previous $2.78 Million 41.16%

% of portfolio

1.19%

Previous 0.86%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$85.0 - $120.04 $1.9 Million - $2.68 Million	22,314 Added 95.43%	45,697 $3.93 Million
Q3 2024 Nov 06, 2024	SELL	$119.07 - $145.42 $75,609 - $92,341	-635 Reduced 2.64%	23,383 $2.78 Million
Q2 2024 Jul 19, 2024	SELL	$122.71 - $146.91 $49,084 - $58,764	-400 Reduced 1.64%	24,018 $3.43 Million
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $52,280 - $69,591	-512 Reduced 2.05%	24,418 $3.14 Million
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $8,778 - $10,545	100 Added 0.4%	24,930 $2.58 Million
Q3 2023 Nov 03, 2023	BUY	$90.94 - $199.54 $1.08 Million - $2.37 Million	11,900 Added 92.03%	24,830 $2.26 Million
Q2 2023 Aug 09, 2023	SELL	$155.98 - $172.65 $17,157 - $18,991	-110 Reduced 0.84%	12,930 $2.09 Million
Q4 2022 Feb 06, 2023	SELL	$102.55 - $135.33 $2,563 - $3,383	-25 Reduced 0.19%	13,040 $1.77 Million
Q3 2022 Nov 08, 2022	BUY	$95.28 - $116.93 $13,815 - $16,954	145 Added 1.12%	13,065 $1.3 Million
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $9,310 - $11,254	100 Added 0.78%	12,920 $1.44 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $62,322 - $76,102	-650 Reduced 4.83%	12,820 $1.44 Million
Q4 2020 Feb 03, 2021	BUY	$63.89 - $73.8 $139,919 - $161,622	2,190 Added 19.41%	13,470 $941,000
Q2 2020 Aug 05, 2020	SELL	$58.54 - $67.94 $585 - $679	-10 Reduced 0.09%	11,280 $739,000
Q1 2020 Apr 30, 2020	SELL	$49.46 - $64.78 $9,892 - $12,956	-200 Reduced 1.74%	11,290 $680,000
Q3 2019 Oct 25, 2019	SELL	$47.54 - $53.43 $3,565 - $4,007	-75 Reduced 0.65%	11,490 $594,000
Q2 2019 Aug 13, 2019	SELL	$46.79 - $52.47 $14,037 - $15,741	-300 Reduced 2.53%	11,565 $590,000
Q1 2019 May 06, 2019	SELL	$46.36 - $52.63 $18,544 - $21,052	-400 Reduced 3.26%	11,865 $621,000
Q4 2018 Feb 13, 2019	SELL	$41.54 - $47.25 $40,501 - $46,068	-975 Reduced 7.36%	12,265 $565,000
Q2 2018 Aug 08, 2018	SELL	$44.29 - $50.42 $8,858 - $10,084	-200 Reduced 1.49%	13,240 $611,000
Q1 2018 May 14, 2018	BUY	$48.49 - $58.14 $4,849 - $5,814	100 Added 0.75%	13,440 $662,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,340	13,340 $572,000

Others Institutions Holding NVO

# of Institutions

1,852

Shares Held

335M

Call Options Held

6.9M

Put Options Held

7.82M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $178B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Meridian Investment Counsel Inc. with notifications on news.

Account

Meridian Investment Counsel Inc. Novo Nordisk A S Transaction History